Tag: nanotechnology
-
Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors
Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment.
-
RNA Cancer Immunotherapy Shown Feasible in Preclinical Test
Tests with lab animals show synthetic viral RNA particles, encased in natural oils, can safely invoke an immune response to attack solid tumors.
-
Cell, mRNA Therapy Biotech Raises $165M in Early Funds
A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body.
-
CEPI Funds New Broad Coronavirus Vaccine
An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells.
-
Semiconductor Tech Drug Discovery Company Underway
A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds.
-
NIH Funding Nanoparticle Gene Therapy for Opioid Disorder
National Institutes of Health is funding research on an experimental gene therapy delivered with nanoparticles to treat opioid use disorder.
-
New Industry, Academic Studies Arrive at Space Station
Several experiments from companies and academic labs arrived today at the International Space Station to test effects of microgravity and other conditions.
-
Exosomes Shown to Block Broad Covid-19 Variant Range
Tiny natural bubbles with infection-receptor proteins found in blood are shown in lab mice to divert and prevent SARS-CoV-2 viruses from infecting real cells.
-
Biotech Partners on Gene Editing Tech in $1.35B Deal
A biotechnology company is making its precise gene editing technology available to drug maker Pfizer for rare diseases, in a deal valued at $1.35 billion.
-
Trial Set for Covid-19 Nasal Spray Vaccine
A clinical trial testing a vaccine to protect against Covid-19 disease, given as a nasal spray, is scheduled to begin later this year in the Netherlands.